Showing results (1-10 of 278) with videos related to
Sort By:
Pageof 28
Biochemical Pharmacology|December 15, 1989
Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs--1. In vitro studies of ibuprofen and flurbiprofenR D Knihinicki, K M Williams, R O DayBiochemical Pharmacology|October 24, 1991
Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs--II. Racemization and hydrolysis of (R)- and (S)-ibuprofen-CoA thioestersR D Knihinicki, R O Day, K M WilliamsAgents and Actions|November 1, 1991
Pharmacokinetics of the enantiomers of ibuprofen in the rabbitK M Williams, R D Knihinicki, R O DayInternal Medicine Journal|June 5, 2007
Has the use of disease-modifying anti-rheumatic drugs changed as a consequence of controlled access to high-cost biological agents through the Pharmaceutical Benefits Scheme?C Y Lu, K M Williams, R O DayInternal Medicine Journal|January 18, 2006
Access to tumour necrosis factor inhibitors for rheumatoid arthritis treatment under the Australian Pharmaceutical Benefits Scheme: are we on target?C Y Lu, K M Williams, R O DayInternational Journal of Clinical Pharmacology and Therapeutics|May 1, 1995
The effect of tenoxicam on tolbutamide pharmacokinetics and glucose concentrations in healthy volunteersR O Day, G Geisslinger, P Paull, et al.British Journal of Clinical Pharmacology|January 1, 1994
Neither cimetidine nor probenecid affect the pharmacokinetics of tenoxicam in normal volunteersR O Day, G Geisslinger, P Paull, et al.Arthritis and Rheumatism|June 1, 1991
The pharmacokinetics of total and unbound concentrations of tenoxicam in synovial fluid and plasmaR O Day, K M Williams, S Graham, et al.Clinical Pharmacokinetics|May 1, 1999
Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluidR O Day, A J McLachlan, G G Graham, et al.Chirality|January 1, 1990
Stereoselective disposition of ibuprofen and flurbiprofen in ratsR D Knihinicki, R O Day, G G Graham, et al.Pageof 28